Literature DB >> 2782353

Rapid determination of fetal sex by deoxyribonucleic acid amplification of Y chromosome-specific sequences.

T L Pinckert1, R V Lebo, M S Golbus.   

Abstract

Rapid fetal sex tests use either dot blot hybridization to Y chromosome-specific (male) repeat sequences or polymerase chain reaction deoxyribonucleic acid amplification of these Y-specific sequences. We have performed 35 fetal sex determinations, 16 by dot blot alone, 13 by polymerase chain reaction alone, and 6 by dot blot and polymerase chain reaction on samples of fetal blood, amniotic fluid, and chorionic villi. All results have been confirmed by karyotyping. Dot blots have given false-positive "male" results three times. In contrast, the polymerase chain reaction has correctly determined fetal sex in every case, even when the dot blot was in error. The Y-specific polymerase chain reaction has been applied to fetal deoxyribonucleic DNA with a chromosome 15; Y translocation to identify the origin of the translocated material. Thus the polymerase chain reaction appears to be a reliable method to rapidly determine fetal sex that also can be used diagnostically to identify translocated Y-chromosomal material.

Mesh:

Year:  1989        PMID: 2782353     DOI: 10.1016/0002-9378(89)90382-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Rapid determination of fetal sex using amniotic fluid cells and the polymerase chain reaction.

Authors:  O Kurauchi; H Yagami; M Kasugai; S Mizutani; Y Tomoda
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

2.  Molecular diagnosis of sex chromosome aneuploidy using quantitative PCR.

Authors:  G L Mutter; R J Pomponio
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

3.  Prenatal diagnosis of Duchenne muscular dystrophy by fetal muscle biopsy.

Authors:  J A Kuller; E P Hoffman; M H Fries; M S Golbus
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.